Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Sida 1 från 27 resultat
Lymphoid Tyrosine Phosphatase Gene Polymorphisms in Inflammatory Bowel Disease
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The inflammatory bowel diseases (IBD) are chronic inflammatory disorders of the gastrointestinal tract that manifests as Crohn's disease (CD) and Ulcerative colitis (UC), clinically characterized by periods of remission interrupted by episodes of clinical disease activity (Zallot et al., 2013).
MyIBD Care - Feasibility Study
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
15 million people in the England suffer from long term conditions (LTCs). Furthermore, the number of people with three or more LTC's has risen from 1.9 million people in 2008 to 2.9 million in 2018. And with the growing number of people suffering from these conditions, the pressure grows for health
Inflammatory Bowel Disease Tracker (IBD Tracker)
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Inflammatory Bowel Disease (IBD) is a chronic, incurable, life-long condition that significantly negatively impacts a patient's quality of life, and increases their risk of developing colorectal cancer. The causes of IBD are currently unknown, but are thought to be a combination of factors related
Clinical Hypnosis in Pediatric Crohn's Disease
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Individualization Treatment Through a Self-managed Web-based Solution in Ulcerative Colitis
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
More than 3 million Europeans suffer from inflammatory bowel disease (IBD), where Crohn's Disease (CD) and Ulcerative Colitis (UC) are the most common forms. They are chronic, relapsing and remitting diseases resulting in uncontrolled inflammation of the gastrointestinal (GI) tract with symptoms of
the Prophylaxis of Recurrent Pouchitis After Fecal Microbiota Transplant in UC With Ileo-anal Anastomosis
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This is a non-randomized, open-label, multi-site phase II therapeutic trial of pembrolizumab and bavituximab in patients with locally advanced HCC. Locally advanced or metastatic HCC is defined as disease that is not amenable to surgical and/or locoregional therapies. Subjects must not have received
Clinical Observational Study: IBD Patients With Restless-legs-syndrome and Iron Deficiency Syndrome
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Restless legs syndrome (RLS) is a common neurological disease significantly impacting live quality. Two recent studies from North America and Japan revealed a surprisingly high prevalence for RLS in Crohn´s disease and ulcerative colitis (30% and 21%, respectively). The underlying cause for this
Role of Multislice CT in Diagnosis of Inflammatory Bowel Disease
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Inflammatory bowel disease (IBD): is a chronic idiopathic disease affecting the gastrointestinal (GI) tract that is comprised of two separate, but related intestinal disorders; Crohn s disease (CD) and ulcerative colitis (UC), IBD is thought to result from an exaggerated and inappropriate immune
Autologous Stem Cell Transplant for Crohn's Disease
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Crohn's Disease Inflammatory bowel disease, encompassing Crohn's disease (CD) and ulcerative colitis (UC), represent incurable chronic inflammatory disorders of the intestinal tract. Patients with IBD experience a chronic relapsing and remitting course of their disease, with little ability to
Low Dose Interleukin-2 in Patients With Stable Ischaemic Heart Disease and Acute Coronary Syndromes
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This Phase I/II trial will carefully examine the safety of low-dose IL-2 in cardiovascular patients where it is currently contraindicated. The planned doses will be given to the trial patients once a day, over five days as subcutaneous injections [ i) Part A : Repeated doses will be given in the
Identifying a Sleep Screener for Disease Relapse in Children With Inflammatory Bowel Disease
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Hypothesis: In children with IBD, high scores for a sleep disturbance screener will be positively associated with IBD relapse
Project Design and Specific Objective: This is a single centre pediatric observational prospective study to develop a non-invasive non-costly tool to screen for relapses in
Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
IBD often presents clinically as abdominal pain, diarrhea (with and without blood), fever, weight loss, failure to thrive, and many related symptoms. Complications of the disorders may also include anemia, skin rashes, arthritis, severe chronic fatigue, and eye inflammatory changes.
It is felt that
Clinical Burden of Anemia in Inflammatory Bowel Disease (RIDART1)
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
Anemia is the most common extraintestinal manifestation of IBD, occurring in 6 to 74 percent of patients. This wide range in the prevalence of anemia is related to differences in study design, in the criteria used to define anemia and to the increasing awareness of anemia in these
Anemia in Inflammatory Bowel Disease
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
1. Study Design:
Two hundred (200) patients with inflammatory bowel disease in remission - 100 patients with Crohn's disease and 100 patients with ulcerative colitis - will be randomly selected.
The patients will be informed that their participation in the study will generate no expense or financial
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
